Top compounds associated with response to SIRPG


Feature Type Standardized
Nominal ANOVA
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.048 0.2
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.065 0.2
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.049 0.2
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.058 0.2
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.048 0.2
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.046 0.2
mRNA PIK-93 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.2
mRNA fingolimod CTRPv2 pan-cancer AAC 0.047 0.2
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.04 0.2
Download CSV